Skip to main content
. 1998 Mar;9(3):561–573. doi: 10.1091/mbc.9.3.561

Table 1.

Hyperosmotic glucose, HGF, and TNFα stimulate JNK1 activity, which is blocked by expression of dominant-negative RasN17, dominant-negative Rac1N17, dominant-negative Cdc42N17, dominant-negative SEK1, and dominant-negative JNK1, but not by expression of dominant-negative c-Jun(TAM67)

Glucose null RasN17 Rac1N17 Cdc42N17 SEK1 JNK1 c-Jun(TAM67)
Control 3,719 ± 570 1,627 ± 180a 833 ± 180a 533 ± 90a 1,605 ± 220a 2,172 ± 300a 4,438 ± 190
Glucose 10,168 ± 2,400b 1,377 ± 330a 929 ± 50a 1,184 ± 320a 2,567 ± 140a 2,107 ± 110a 11,313 ± 1,050b
HGF 12,585 ± 1,820b 1,711 ± 410a 1,263 ± 290a 1,517 ± 280a 2,564 ± 380a 1,873 ± 220a 11,647 ± 1,670b
TNFα 12,440 ± 1,750b 1,710 ± 240a 1,596 ± 300a 1,851 ± 60a 1,897 ± 180a 2,559 ± 145a 12,647 ± 770b

Hepatocytes were infected with either control plasmid poly-l-lysine adenovirus or dominant-negative Ras N17/Rac1 N17/Cdc42 N17/SEK1/JNK1 poly-l-lysine adenovirus (250 moi), followed by culture as described in MATERIALS AND METHODS. In a parallel experiment, hepatocytes were infected with a recombinant adenovirus (250 moi) to express a nontransactivatable dominant-negative c-Jun(TAM67). After 24 h to allow expression of dominant-negative gene products, hepatocytes were treated for 10 min with either media control, 50 mM glucose, 1 ng/μl HGF, or 1 ng/μl TNFα. After 10 min, media were aspirated and cells frozen. Hepatocytes were lysed and subjected to immunoprecipitation followed by immune complex kinase assays for JNK1. Activities shown are expressed as cpm incorporated into substrate versus media control treatment (5000 cpm/pmol) and are the means ± SE from two to five experiments, each performed in duplicate. 

a

p < 0.05 decrease compared with corresponding value in null/control plasmid infected. 

b

p < 0.05 increase compared with control.